Suppression of Coronary Atherosclerosis by Helix B Surface Peptide, a Nonerythropoietic, Tissue-Protective Compound Derived from Erythropoietin
Hiroto Ueba(Jichi Medical University), Masanobu Kawakami(Jichi Medical University), Michael Brines(Northwell Health), Michael Yamin, Tsutomu Kobayashi(Kyoto first Red Cross hospital), Shin‐ichi Momomura, Junya Ako(E Ink (South Korea)), Masashi Shiomi(Toujinkai Hospital), Anthony Cerami(Araim Pharmaceuticals (United States))
Cited by 25
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor
|Proceedings of the National Academy of Sciences|2004|654